Sub-epidemics explain localized high prevalence of reduced susceptibility to Rilpivirine in treatment-naive HIV-1-infected patients: subtype and geographic compartmentalization of baseline resistance mutations
- Publication date
- 1 May 2016
- Publisher
- 'Mary Ann Liebert Inc'